A randomized phase II trial of best supportive care with or without hyperthermia and vitamin C for heavily pretreated, advanced, refractory non-small-cell lung cancer

A randomized phase II trial of best supportive care with or without hyperthermia and vitamin C for heavily pretreated, advanced, refractory non-small-cell lung cancer

Our previous study indicated that intravenous vitamin C (IVC) treatment concurrent with modulated electrohyperthermia (mEHT) was safe and improved the quality of life (QoL) of non-small-cell lung cancer (NSCLC) patients. The aim of this trial was to further verify the efficacy of the above combinati...

Full description

Bibliographic Details
Main Authors: Junwen Ou, Xinyu Zhu, Pengfei Chen, Yanping Du, Yimin Lu, Xiufan Peng, Shuang Bao, Junhua Wang, Xinting Zhang, Tao Zhang, Clifford L.K. Pang
Format: Article
Language:English
Published: Elsevier 2020-07-01
Series:Journal of Advanced Research
Subjects:
Vitamin C
Modulated electrohyperthermia
Non-small-cell lung cancer
Overall survival
Quality of life
Remission rate
Online Access:http://www.sciencedirect.com/science/article/pii/S2090123220300539

Internet

http://www.sciencedirect.com/science/article/pii/S2090123220300539

Similar Items